EssilorLuxottica stock rebounds as Nuance glasses gain FDA clearance

Published on 09/23/2026 at 14:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EssilorLuxottica stock closed at EUR 145.60 on September 22, 2026, after a 3.1 percent rise. Second-quarter revenue reached EUR 7.692 billion, up 7.2 percent.

Photorealistic studio shot of a generic designer eyeglass frame on white background — EssilorLuxottica FR0000033219 editorial shot of unbranded titanium designer eyeglass frame on white background, Illustration mit AI erstellt.

EssilorLuxottica (ISIN FR0000033219) stock closed at EUR 145.60 on September 22, 2026, after gaining 3.1 percent in Paris. The move followed FDA clearance for the companys Nuance Audio Plus hearing glasses, while second-quarter 2026 revenue reached EUR 7.692 billion, up 7.2 percent year over year.

FDA clearance expands the market

According to Ad Hoc News on September 23, 2026, Nuance Audio Plus received US clearance for over-the-counter sales. The device starts at USD 829 and removes the need for a doctors consultation before purchase.

The product is aimed at a large unmet need. The company estimates that about 1.25 billion people worldwide live with mild to moderate hearing loss, while nearly 90 percent lack an adequate solution, according to the same September 23, 2026 report from Ad Hoc News.

Revenue growth meets new technology

For the second quarter of 2026, revenue was EUR 7.692 billion, 7.2 percent higher than a year earlier. Myopia-management revenue increased 24 percent in the quarter, while AI-glasses revenue nearly doubled, according to Ideal Investisseur in its September 22, 2026 market report.

The latest half-year figures also showed an adjusted operating margin of 15.5 percent and free cash flow of EUR 1.07 billion, up EUR 100 million, for the first half of 2026. The margin was 18.6 percent at constant exchange rates, compared with 18.9 percent on the same basis in the first half of the previous year, according to Ideal Investisseur.

RBC cuts target as shares remain weak

RBC Capital Markets maintained its Outperform rating on September 22, 2026, but reduced its price target from EUR 230 to EUR 190, as reported by Ideal Investisseur. The revised target remains EUR 44.40 above the September 22 closing price, but the reduction shows that expectations have been reset after the share-price decline.

Technical pressure remains visible: the stock stood below the 20-day moving average at EUR 151.28, the 50-day average at EUR 160.32 and the 200-day average at EUR 202.05 on September 22, 2026. The same report identified EUR 139 as a support level after the recent low of EUR 138.85.

Stock closes at EUR 145.60

EssilorLuxottica stock closed at EUR 145.60 on Euronext Paris on September 22, 2026, up 3.1 percent on the day. The close was 55 percent below the reported 52-week high, while the shares were down 46 percent since the start of 2026.